Evidence map›Paper›PMID 30943996›Full record

ArticleParticle and fibre toxicology2019

A novel human 3D lung microtissue model for nanoparticle-induced cell-matrix alterations.

Pranita K Kabadi, April L Rodd, Alysha E Simmons, Norma J Messier, Robert H Hurt, Agnes B Kane

Open access · goldAbstract read
In one paragraph

Article in Particle and fibre toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. The evolution ofEuropean respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Lung Organoids for Hazard Assessment of Nanomaterials.International journal of molecular sciences · 2022
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pranita K KabadiDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, 02912, USA.
April L RoddDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, 02912, USA. April_Rodd@brown.edu.ORCID 0000-0001-9404-2751
Alysha E SimmonsDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, 02912, USA.
Norma J MessierDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, 02912, USA.
Robert H HurtSchool of Engineering, Brown University, Providence, Rhode Island, 02912, USA.
Agnes B KaneDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, 02912, USA. Agnes_Kane@brown.edu.
Brown University · US

Funding

Vapor Pressures and Thermodynamic Properties of Complex Organic MixturesP42ES013660 · NIEHS · BROWN UNIVERSITY · PI BOEKELHEIDE, KIM, HURT, ROBERT H. · 2005 to 2020
$37.7M
TRAINING IN ENVIRONMENTAL PATHOLOGYT32ES007272 · NIEHS · BROWN UNIVERSITY · PI ZHITKOVICH, ANATOLY · 1992 to 2021
$7.5M
Human 3D Microtissues for Toxicity Testing via Integrated Imaging, Molecular and Functional AnalysesU01ES028184 · NIEHS · BROWN UNIVERSITY · PI BOEKELHEIDE, KIM, MORGAN, JEFFREY R · 2017 to 2021
$3.8M
NIEHS NIH HHS P42 ES013660NIEHS NIH HHS P42ES013660NIEHS NIH HHS T32 ES007272NIEHS NIH HHS T32ES007272NIEHS NIH HHS U01 ES028184
6 · The paper itself

Abstract

backgroundMulti-walled carbon nanotubes (MWCNT) have been shown to elicit the release of inflammatory and pro-fibrotic mediators, as well as histopathological changes in lungs of exposed animals. Current standards for testing MWCNTs and other nanoparticles (NPs) rely on low-throughput in vivo studies to assess acute and chronic toxicity and potential hazard to humans. Several alternative testing approaches utilizing two-dimensional (2D) in vitro assays to screen engineered NPs have reported conflicting results between in vitro and in vivo assays. Compared to conventional 2D in vitro or in vivo animal model systems, three-dimensional (3D) in vitro platforms have been shown to more closely recapitulate human physiology, providing a relevant, more efficient strategy for evaluating acute toxicity and chronic outcomes in a tiered nanomaterial toxicity testing paradigm.

resultsAs inhalation is an important route of nanomaterial exposure, human lung fibroblasts and epithelial cells were co-cultured with macrophages to form scaffold-free 3D lung microtissues. Microtissues were exposed to multi-walled carbon nanotubes, M120 carbon black nanoparticles or crocidolite asbestos fibers for 4 or 7 days, then collected for characterization of microtissue viability, tissue morphology, and expression of genes and selected proteins associated with inflammation and extracellular matrix remodeling. Our data demonstrate the utility of 3D microtissues in predicting chronic pulmonary endpoints following exposure to MWCNTs or asbestos fibers. These test nanomaterials were incorporated into 3D human lung microtissues as visualized using light microscopy. Differential expression of genes involved in acute inflammation and extracellular matrix remodeling was detected using PCR arrays and confirmed using qRT-PCR analysis and Luminex assays of selected genes and proteins.

conclusion3D lung microtissues provide an alternative testing platform for assessing nanomaterial-induced cell-matrix alterations and delineation of toxicity pathways, moving towards a more predictive and physiologically relevant approach for in vitro NP toxicity testing.

Indexed as

Models, BiologicalAnimal Testing AlternativesAsbestos, CrocidoliteCell SurvivalCoculture TechniquesEpithelial CellsExtracellular MatrixFibroblastsHumansLungMacrophagesNanotubes, CarbonToxicity TestsAsbestos, CrocidoliteNanotubes, CarbonCell-matrix interactionsHuman lung microtissuesIn vitro testing methodsMulti-walled carbon nanotubesNanoparticlesThree-dimensional spheroids

Identifiers

PMID30943996
PMCPMC6448215
OpenAlexW2944461943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.